[Sponsored] Megan Zakrewsky, vice president of product at Veradigm talks about how the company is utizing tech among providers, payers and patients. Watch now! The post MedCity Pivot: How Veradigm Aims to Close the Information Gap appeared first on MedCity News.
UnitedHealth Group announced that Andrew Witty will step down as CEO due to “personal reasons.” He is being replaced by Stephen J. Hemsley, who served as the company’s CEO from 2006 to 2017. The post How Social Media Is Reacting to UnitedHealth Group’s CEO Exit and Stock Meltdown appeared first on MedCity News.
During a panel at the Reuters Digital Health conference in Nashville, health system executives shared what they’ve learned about navigating change in tech pilots. In their view, success is determined by cultural readiness, frontline staff buy-in and a clear-eyed view of what success looks like. The post What Hospitals Have Learned About Change Management in…
Galapagos has dropped plans for a business separation that would have enabled the legacy company to focus exclusively on developing new cancer cell therapies. Instead, Galapagos said it will pursue strategic alternatives for its assets. The post Galapagos Says ‘No’ to SpinCo and Instead Will Seek Deals for All Assets appeared first on MedCity News.
Women most affected by both functional and serious GI conditions, especially in midlife, are often dismissed, misdiagnosed, or forced to endure prolonged waits for specialist care. The post Dismissed, Delayed — and Done Waiting: The GI Crisis Midlife Women Can’t Afford appeared first on MedCity News.
[Sponsored] PurpleLab and Genentech executives will explore how to leverage real world data to eliminate blind spots in the patient journey — informing every phase of a drug’s lifecycle, from clinical development to market access — in a May 22 webinar. The post Improving the Patient Journey in Drug Development appeared first on MedCity News.
By creating payment experiences that feel less like a burden and more like the seamless, convenient, flexible transactions patients experience elsewhere, we can significantly improve both patient satisfaction and financial performance. The post Bridging Financial Services and Healthcare appeared first on MedCity News.
[Sponsored] In a webinar sponsored by fintech business Mercury, investors from Breyer Capital and MBX Capital shared their startup trend perspectives on AI, valuation, and alternative funding. The post Investors Share How Early Stage Healthcare and Life Science Startups Can Make the Most of New Opportunities appeared first on MedCity News.
Healthtech companies have to navigate a maze of complex regulations, prove their financial model, and win over multiple stakeholders. Finding the right balance between patient protection and innovation is crucial. The post Barriers and Pathways to Healthtech Adoption in Clinical Practice appeared first on MedCity News.
President Trump’s executive order provides a framework for tying the prices of U.S. pharmaceutical products to the lower prices paid in other countries, what’s called most-favored-nation pricing. If drug companies do not lower their prices accordingly, the order proposes other strategies, such as importing drugs from other countries. The post Trump Strategy to Rein In…